Page last updated: 2024-10-16

5-hydroxytryptophan and Amyotrophic Lateral Sclerosis

5-hydroxytryptophan has been researched along with Amyotrophic Lateral Sclerosis in 2 studies

5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Turner, BJ1
Lopes, EC1
Cheema, SS1
Akiguchi, I1
Kato, T1
Sugiyama, H1

Other Studies

2 other studies available for 5-hydroxytryptophan and Amyotrophic Lateral Sclerosis

ArticleYear
The serotonin precursor 5-hydroxytryptophan delays neuromuscular disease in murine familial amyotrophic lateral sclerosis.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2003, Volume: 4, Issue:3

    Topics: 5-Hydroxytryptophan; Aging; Alanine; Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Body

2003
[Trials of 1-cysteine, TRH and 5HTP in amyotrophic lateral sclerosis].
    Rinsho shinkeigaku = Clinical neurology, 1984, Volume: 24, Issue:12

    Topics: 5-Hydroxytryptophan; Administration, Oral; Amyotrophic Lateral Sclerosis; Cysteine; Drug Evaluation;

1984